Global Constipation-Laxative Market Overview:
The global constipation laxative market is set to witness steady growth, expanding at a CAGR of 5.7% during the forecast period (2020-2030). The market is set to reach a value pool of US$ 10.8 Bn through 2030. Opioid Induced Constipation (OIC) is the most prevalent side-effect post consumption of a certain class of drugs and may negatively impact patients’ adherence to analgesic prescriptions. OIC accounts for six out of ten non-cancer patients receiving opioids.
In addition, various metabolic disorders are also responsible for constipation. Diabetics are two times more susceptible to constipation than non-diabetic patients. Based on the aforementioned factors, the use of constipation laxatives has soared and will continue to find enhanced growth prospects in the future.
Global Constipation-Laxative Market Analysis by Mode of Mechanism
Bulk-forming laxatives are anticipated to capture the maximum market share, accounting for over one-third of the global constipation laxatives market throughout the forecast period. At the same time, the stimulants segment is poised to expand the fastest at a CAGR of 6.0%.
Ease of ingestion and gradual improvement of symptoms are the main factors behind increased preference for bulk-forming laxatives. Additionally, these laxatives also prevent the occurrence of explosive diarrhea, a common side-effect of stimulant laxatives. Bulk-forming laxatives also improve medical conditions such as hemorrhoids, anal fissures and hernia. Increased usage of stimulant-based laxatives is attributed to its immediate effectiveness, especially suppositories which work in as little as half-an-hour.
Global Constipation Laxative Market: Regional Insights:
North America and Europe collectively, shall account for over three-fifth of the global constipation-laxative market during the forecast period. While North America is poised to expand at a CAGR of ~5.5%, Europe shall expand at ~6.0%.
Increasing prevalence of constipation, growing awareness about gastrointestinal infections and increased support from the government to develop adequate healthcare infrastructure are some important factors driving market growth of constipation laxatives in North America and Europe.
Global Constipation Laxative Market Manufacturers
The global constipation-laxative market is consolidated. Prominent market players dominating the market include: GlaxoSmithKline, Bayer AG, Sanofi, Takeda, Abbott Laboratories and Purdue Pharma LP. The top five key players accounted for approximately 57.8% revenue share in 2019, while the remaining players accounted for over 40% of the revenue.
Manufacturers are concentrating on research and development to launch new branded generic products to create incremental dollar opportunities by targeting emerging economies.
Some market players are also resorting to online sales platforms for marketing over-the-counter laxative brands. Less prominent players are concentrating on mergers and acquisitions in order to establish market presence. For instance, in 2018, Mallinckrodt Pharmaceuticals acquired Sucampo Pharmaceuticals to leverage their industry leading capabilities and R&D capabilities to accelerate innovation.
Avail customized purchase options for your needs
COVID-19’s Impact on Constipation Laxatives Market:
The coronavirus outbreak is a human tragedy, affecting millions of people worldwide. Even today, COVID-19 is continuously expanding its tentacles, paralyzing all economic activity and hindering production capabilities. The International Monetary Fund has estimated that global growth is anticipated to fall by 3% throughout the remainder of 2020.
Additionally, cost of raw materials to manufacture important drugs has augmented. Based on these trends, it is prudent to conclude that the world is headed towards a massive recession in the coming months.
Fortunately, the impact of COVID-19 on the constipation-laxatives market has been minimal. The laxative market is flooded with different brands from leading as well as mid-sized manufacturers offering products with different dosages.
Manufacturers have established strong collaborations with distribution chain partners to strengthen the supply chain of laxative products for adult patients suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic conditions. This continuity of the supply chain is anticipated to keep the constipation-laxative market afloat throughout the duration of the pandemic.
“Rising adoption of sedentary lifestyles has led to a reduced intake of water by individuals in the wake of reduced physical activity. As a consequence, incidence of constipation has increased in both the developing and developed countries. This is expected to burgeon market prospects in the future.”
An Adaptive Approach to Modern-day Research Needs
Global Constipation Laxative Market: Report Scope:
The recent study undertaken by Fact.MR on the global constipation laxative market offers a decade-long forecast ranging from 2020 to 2030 and a historical analysis from 2015 to 2020. The report explicates on vital dynamics such as the drivers, opportunities and restraints impacting future growth of the market. The market has been analyzed in detail based on the following segments: Mode of Mechanism, Route of Administration and Distribution Channel.
A regional landscape has also been mapped, providing a region-wise analysis of the abovementioned segments. Regional profiling has been done based on the following regions: North America, Latin America, Europe, South Asia, East Asia, Oceania and Middle East & Africa.
Towards the end of the report, a competitive landscape highlighting key players’ revenue and market share, product launches, key collaborations and mergers and acquisitions has been provided. In addition, a SWOT analysis of each players has been incorporated to provide a realistic outlook.
Constipation Laxative Market: Segmentation
FactMR’s study has done the segmentation of the constipation laxative market on the basis of mode of mechanism, route of administration, distribution channel, across five regions.
Mode of Mechanism
Route of Administration
Need an Exclusive Report for your Unique Requirement?
- Related Reports -
Particle-Enhanced Turbidimetric Immunoassays Market is set to witness steady growth by 2031. Researc...
- Our Clients -
- Evaluate How Fact.MR's Report Can Help. -
Is the market research conducted by Fact.MR?
Yes, the report has been compiled by expert analysts of Fact.MR, through a combination of primary and secondary research. To know more about how the research was conducted, you can speak to a research analyst.
What research methodology is followed by Fact.MR?
Fact.MR follows a methodology that encompasses the demand-side assessment of the market, and triangulates the same through a supply-side analysis. This methodology is based on the use of standard market structure, methods, and definitions.
What are the sources of secondary research?
Fact.MR conducts extensive secondary research through proprietary databases, paid databases, and information available in the public domain. We refer to industry associations, company press releases, annual reports, investor presentations, and research papers. More information about desk research is available upon request.
Who are the respondents for primary research?
Fact.MR speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, and industry experts. For a full list of primary respondents, please reach out to us.
Is a sample of this report available for evaluation?
Yes, you can request a sample, and it will be sent to you through an email.